中文部分
公益財団法人 痛風財団(無日期).痛風にはどんな合併症がありますか?取自 http://www.tufu.or.jp/gout/gout1/47.html
中華民國痛風之友協會(無日期).認識痛風.取自http://www.gout.org.tw/contents/gout.htm
江瑞坤(2008).台灣成人女性素食與非素食生活型態與各項身體因素及血液中化因素的關係(碩士論文).國立臺灣大學,台北市,台灣.取自臺灣博碩士論文知識加值系統。周玉慧、謝雨生(2009).夫妻間支持授受及其影響.中華心理學刊,51(2),215-234。邱皓政、周怡君、林碧芳(2010).[工作設計量表] 信效度衡鑑與工作結構潛在類別分析.測驗學刊,57(1),139-179。風濕病醫學會(2013).台灣痛風與高尿酸血症2013診治指引.取自http://www.rheumatology.org.tw/news/Files/N2014217133733_%B5h%AD%B7%AB%FC%A4%DE0217.pdf
翁碩駿、徐國雄、唐德成、吳明儒(2012).以腎臟科醫師的觀點看高尿酸血症.腎臟與透析, 24(3), 149-154。國家教育研究院(2012).集群分析.取自http://terms.naer.edu.tw/detail/1311901/?index=4
許芳瑾(2003).痛風患者的醫療利用分析(碩士論文).中國醫藥學院,台中市,台灣.取自臺灣博碩士論文知識加值系統。國際糖尿病聯盟(2013).老年第二型糖尿病管理全球指引.取自http://www.idf.org/guidelines/managing-older-people-type-2-diabetes
范碧儒(2012).以潛在類別模式分析影響台灣中老年人之憂鬱因子(未發表之碩士論文).國立成功大學,台南市,台灣。張德明(2006).痛風與其他疾病或問題的關連.健康世界,243,16-18。黃麗玲、林川雄、黃建財(2005).痛風與高尿酸血症的認知與管理.輔仁醫學期刊,3(1),25-32。楊仲凱(2011).探討痛風與慢性腎臟病患死於心血管疾病的風險(碩士論文). 亞洲大學,台中市,台灣.取自臺灣博碩士論文知識加值系統。楊志堅、吳齊殷(2001).潛藏轉移模式在社會學縱貫研究之應用:以青少年暴力行為發展研究為例.調查研究—方法與應用,9,28。衛生福利部國家衛生研究院(2010).2005-2008 國人尿酸及痛風之狀況.取自http://nahsit.nhri.org.tw/node/20
衛生福利部國家衛生研究院(2010).2005-2008國人高血壓之狀況.取自http://nahsit.nhri.org.tw/node/34
潘文涵、吳幸娟、葉志嶸、莊紹源、張新儀、葉乃華、謝耀德(2009).台灣人飲食與健康之趨勢:1993-1996與 2005-2008營養健康調查之比較.2005-2008台灣營養健康調查成果發表會,台北市,台灣。
葉慶輝、吳香錡(2011).台灣南部健檢成人高尿酸血症與新陳代謝症候群之相關性探討.中華職業醫學雜誌,18(3),197-210。陳水湖、莊紹源、周碧瑟(2005).1991-1994年金門縣30歲以上成人高尿酸血症盛行率與危險因子研究.臺灣公共衛生雜誌,24(1),73-83。陳怡如(2007).高尿酸血症與痛風.基層醫學,22(1),9-16。蔡東華、林世鐸(2008).中臺灣地區高尿酸血症個體之代謝症候群盛行率.內科學誌,19(4),325-330。謝美芬、顏兆熊(2011).高尿酸血症與痛風.當代醫學,455,654-662。優活健康網(2009).不只是痛風而已-治療痛風的全面觀.取自http://www.uho.com.tw/sick.asp?aid=7275
顏學儀(2004).信義鄉居民痛風相關因素之家族資料研究(碩士論文).中國醫藥大學,台中市,台灣.取自臺灣博碩士論文知識加值系統。英文部分
Annemans, L., Spaepen, E., Gaskin, M., Bonnemaire, M., Malier, V., Gilbert, T., & Nuki, G. (2008). Gout in the UK and Germany: Prevalence, comorbidities and management in general practice 2000-2005. Annals of the Rheumatic Diseases, 67(7), 960-966. doi: 10.1136/ard.2007.076232
Berger, L., & Yu, T. F. (1975). Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. American Journal of Medicine, 59(5), 605-613.
Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C., & Breteler, M. M. (2006). Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke, 37(6), 1503-1507. doi: 10.1161/01.STR.0000221716.55088.d4
Campion, E. W., Glynn, R. J., & DeLabry, L. O. (1987). Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. American Journal of Medicine, 82(3), 421-426.
Chang, H. Y., Pan, W. H., Yeh, W. T., & Tsai, K. S. (2001). Hyperuricemia and gout in Taiwan: Results from the nutritional and health survey in Taiwan (1993-96). Journal of Rheumatology, 28(7), 1640-1646.
Chen, J. H., Pan, W. H., Hsu, C. C., Yeh, W. T., Chuang, S. Y., Chen, P. Y., . . . Huang, W. L. (2013). Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: A prospective study. Arthritis Care & Research (Hoboken), 65(1), 133-140. doi: 10.1002/acr.21824
Chen, C.J., Yen, J.H., Chang, S.J. (2014) Gout patients have an increased risk of developing most cancers, especially urological cancers. Scandian Journal of Rheumatology. 14:1-33. [Epub ahead of print].
Chen, J. H., Yeh, W. T., Chuang, S. Y., Wu, Y. Y., & Pan, W. H. (2012). Gender-specific risk factors for incident gout: A prospective cohort study. Clinical Rheumatology, 31(2), 239-245. doi: 10.1007/s10067-011-1802-6
Choi, H. K., Atkinson, K., Karlson, E. W., & Curhan, G. (2005). Obesity, weight change, hypertension, diuretic use, and risk of gout in men: The health professionals follow-up study. Archives of Internal Medicine, 165(7), 742-748. doi: 10.1001/archinte.165.7.742
Chuang, S. Y., Lee, S. C., Hsieh, Y. T., & Pan, W. H. (2011). Trends in hyperuricemia and gout prevalence: Nutrition and health survey in Taiwan from 1993-1996 to 2005-2008. Asia Pacific Journal of Clinical Nutrition, 20(2), 301-308.
Clarke, P. M., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S. B., & Salomon, J. A. (2010). Event rates, hospital utilization, and costs associated with major complications of diabetes: A multicountry comparative analysis. PLOS Medicine, 7(2), e1000236. doi: 10.1371/journal.pmed.1000236
Collins, L. M., & Lanza, S. T. (2010). Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences (Vol. 718). New York , John Wiley & Sons.
De Vera, M. A., Rahman, M. M., Bhole, V., Kopec, J. A., & Choi, H. K. (2010). Independent impact of gout on the risk of acute myocardial infarction among elderly women: A population-based study. Annals of the Rheumatic Diseases, 69(6), 1162-1164. doi: 10.1136/ard.2009.122770
Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., . . . Groop, L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4), 683-689.
Juraschek, S. P., Kovell, L. C., Miller, E. R., 3rd, & Gelber, A. C. (2013). Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010. Seminars in Arthritis and Rheumatism, 42(6), 551-561. doi: 10.1016/j.semarthrit.2012.09.009
Khanna, P. P., Nuki, G., Bardin, T., Tausche, A. K., Forsythe, A., Goren, A., . . . Khanna, D. (2012). Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health and Quality of Life Outcomes, 10, 117. doi: 10.1186/1477-7525-10-117
Krishnan, E., Lingala, B., & Bhalla, V. (2012). Low-level lead exposure and the prevalence of gout: An observational study. Annals of Internal Medicine, 157(4), 233-241. doi: 10.7326/0003-4819-157-4-201208210-00003
Krishnan, E., Svendsen, K., Neaton, J. D., Grandits, G., & Kuller, L. H. (2008). Long-term cardiovascular mortality among middle-aged men with gout. Archives of Internal Medicine, 168(10), 1104-1110. doi: 10.1001/archinte.168.10.1104
Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2014). Rising burden of gout in the UK but continuing suboptimal management: A nationwide population study. Annals of the Rheumatic Diseases. doi: 10.1136/annrheumdis-2013-204463
Kuo, C. F., Grainge, M. J., See, L. C., Yu, K. H., Luo, S. F., Valdes, A. M., . . . Doherty, M. (2013). Familial aggregation of gout and relative genetic and environmental contributions: A nationwide population study in Taiwan. Annals of the Rheumatic Diseases. doi: 10.1136/annrheumdis-2013-204067
Kuo, C. F., Luo, S. F., See, L. C., Chou, I. J., Fang, Y. F., & Yu, K. H. (2012). Increased risk of cancer among gout patients: A nationwide population study. Joint Bone Spine, 79(4), 375-378. doi: 10.1016/j.jbspin.2011.09.011
Kuo, C. F., Yu, K. H., See, L. C., Chou, I. J., Ko, Y. S., Chang, H. C., . . . Luo, S. F. (2013). Risk of myocardial infarction among patients with gout: A nationwide population-based study. Rheumatology (Oxford, England), 52(1), 111-117. doi: 10.1093/rheumatology/kes169
Lazarsfeld, P. F., & Henry, N. W. (1968). Latent structure analysis. Houghton, Mifflin.
Lee, M. Y., Lin, K. D., Hsiao, P. J., & Shin, S. J. (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61(2), 242-249. doi: 10.1016/j.metabol.2011.06.020
Lin, K. C., Lin, H. Y., & Chou, P. (2000). Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. Journal of Rheumatology, 27(4), 1045-1050.
Lin, K. C., Lin, H. Y., & Chou, P. (2000). The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. Journal of Rheumatology, 27(6), 1501-1505.
Lin, K. C., Tsao H.M., Chen, C.H., & Chou, P. (2004). Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia. Journal of Rheumatology, 31(6):1152-8.
Lin, K. C., Tsai, S.T., Lin, H.Y., & Chou, P. (2004). Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. Journal of Rheumatology, 31(6):1159-65.
Miao, Z., Li, C., Chen, Y., Zhao, S., Wang, Y., Wang, Z., . . . Wang, C. Y. (2008). Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. Journal of Rheumatology, 35(9), 1859-1864.
Mikuls, T. R., Farrar, J. T., Bilker, W. B., Fernandes, S., Schumacher, H. R., Jr., & Saag, K. G. (2005). Gout epidemiology: Results from the UK general practice research database, 1990-1999. Annals of the Rheumatic Diseases, 64(2), 267-272. doi: 10.1136/ard.2004.024091
Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., & Dietz, W. H. (1999). The disease burden associated with overweight and obesity. Journal of the American Medical Association, 282(16), 1523-1529.
Pan, W. H., Wu, H. J., Yeh, C. J., Chuang, S. Y., Chang, H. Y., Yeh, N. H., & Hsieh, Y. T. (2011). Diet and health trends in Taiwan: comparison of two nutrition and health surveys from 1993-1996 and 2005-2008. Asia Pacific Journal of Clinical Nutrition, 20(2), 238-250.
Primatesta, P., Plana, E., & Rothenbacher, D. (2011). Gout treatment and comorbidities: A retrospective cohort study in a large US managed care population. BMC Musculoskeletal Disorders, 12, 103. doi: 10.1186/1471-2474-12-103
Rathmann, W., Funkhouser, E., Dyer, A. R., & Roseman, J. M. (1998). Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Coronary artery risk development in young adults. Annals of Epidemiology, 8(4), 250-261.
Reaven, G. M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37(12), 1595-1607.
Richette, P., Clerson, P., Perissin, L., Flipo, R. M., & Bardin, T. (2013). Revisiting comorbidities in gout: A cluster analysis. Annals of the Rheumatic Diseases. doi: 10.1136/annrheumdis-2013-203779
Roddy, E., Muller, S., Hayward, R., & Mallen, C. D. (2013). The association of gout with sleep disorders: A cross-sectional study in primary care. BMC Musculoskeletal Disorders, 14, 119. doi: 10.1186/1471-2474-14-119
Sheane, B. J., & Cunnane, G. (2007). Tophaceous gout and chronic kidney disease. Journal of Clinical Rheumatology, 13(5), 293.
Sotres-Alvarez, D., Herring, A. H., & Siega-Riz, A. M. (2013). Latent transition models to study women's changing of dietary patterns from pregnancy to 1 year postpartum. American Journal of Epidemiology, 177(8), 852-861. doi: 10.1093/aje/kws303
University Park: The Methodology Center, Penn State. (2013). PROC LCA & PROC LTA (Version 1.3.0) [Software]. Retrieved from http://methodology.psu.edu
University Park: The Methodology Center, Penn State. (2013). PROC LCA & PROC LTA users’ guide (Version 1.3.0). Retrieved from http://methodology.psu.edu
Wang, Y., Yan, S., Li, C., Zhao, S., Lv, J., Wang, F., . . . Miao, Z. (2013). Risk factors for gout developed from hyperuricemia in China: A five-year prospective cohort study. Rheumatology International, 33(3), 705-710. doi: 10.1007/s00296-012-2439-8
Ward, H. J. (1998). Uric acid as an independent risk factor in the treatment of hypertension. Lancet, 352(9129), 670-671. doi: 10.1016/s0140-6736(05)60816-1
Winnard, D., Wright, C., Jackson, G., Gow, P., Kerr, A., McLachlan, A., . . . Dalbeth, N. (2013). Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: Co-prevalence and implications for clinical practice. The New Zealand Medical Journal, 126(1368), 53-64.
Zhu, Y., Pandya, B. J., & Choi, H. K. (2011). Prevalence of gout and hyperuricemia in the US general population: The national health and nutrition examination survey 2007-2008. Arthritis & Rheumatology, 63(10), 3136-3141. doi: 10.1002/art.30520
Zhu, Y., Pandya, B. J., & Choi, H. K. (2012). Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. American Journal of Medicine, 125(7), 679-687. doi: 10.1016/j.amjmed.2011.09.033